RxDoctor Payments Data

Brian Giordano, MD

Orthopaedic Surgery · Rochester, NYNPI 1215946843

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (47.8%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 99.7% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $249,503, 3.3 times the $76,660 reported in 2019. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$971,089in general payments, 2019–2025

Across 385 payments — averaging $2522.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$968K
  • Prodigy Surgical Distribution, Inc.$3K
  • Stryker$66
$29,529in research payments, 2019–2025

Across 3 payments — averaging $9843.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$30K

What the payments were for

  • Royalty or licence$463,97048%
  • Consulting fees$54,5206%
  • Speaking & faculty fees$420,54043%
  • Travel & lodging$27,6713%
  • Food & beverage$4,3880%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex373$968,121
Prodigy Surgical Distribution, Inc.11$2,902
Stryker1$66

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$971,089 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$25,855
Medicare patients
59
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →